1 Cannabis Stock You Should Buy Now and 1 You Need to Sell

Cronos Group Inc. (TSX:CRON)(NASDAQ:CRON) and The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) are two cannabis companies that investors are seriously looking at, but are they looking to buy or sell?

| More on:
Man considering whether to sell or buy

Image source: Getty Images.

It’s time to start getting picky about pot stocks.

The dust certainly hasn’t settled yet, though there has been a bit of mellowing out around the marijuana sector. After record highs came some lows, and now investors need to start getting serious about where certain stocks are headed. Hopefully, it’s in an upward direction.

But that means these stocks have a lot to prove. Honestly, I’m not going to waste your time talking about the heavy hitters. I’ll look at one stock opportunity and another stock that I don’t see the brightest of futures for.

Green Organic Dutchman

Green Organic Dutchman (TSX:TGOD) may be a smaller marijuana company, but it’s been making some major moves recently. Now, before I get into them, I want to warn that I don’t think this is a buy-and-hold-for-years type of stock. Green Organic is just in a place where it’s the right time to buy before some major growth and then sell it.

That growth is coming from a few announcements from the company. Most recently, it announced its entrance into the U.S. market by becoming a “co-founding investor and strategic partner in the newly formed Califormulations LLC” to create hemp-derived cannabis beverages.

This came not long after another announcement that the company has reached a settlement with Hamilton City Council on its greenhouse facility in Ancaster, Ontario. The company will now be able to grow 17,500 kilograms of cannabis per year. On top of that, Green Organic opened its second legal cannabis retail store in Jamaica on May 4 in Montego Bay: a popular tourist destination.

Needless to say, this stock is therefore undervalued at its share price of about $4.25 at the time of writing. It’s dropped by about half since its peak last September, and analysts think it’s due to get back to that range, if not surpass it, in the next 12 months alone. That makes now an ideal buying opportunity in the short term.


Often touted as the cannabis company with the most cash, Cronos Group (TSX:CRON)(NASDAQ:CRON), in my view, has hit its peak. That peak was in March, when the company’s shares were just shy of hitting $29 per share and have been dropping ever since to where they sit at the time of writing at $21 per share.

The excitement of last fall has just fallen to the wayside for this stock. After a strong year, the company boasted year-on-year returns of 201.8% recently and was strengthened by its $2.4 billion investment from Altria. But the stock is now seen as overvalued, selling at eight times its future cash flow, 18.8 times its book value, and 79% expected annual growth in earnings.

Don’t get me wrong; the company still has a few tricks up its sleeve. For instance, it recently announced the expansion of its global infrastructure network to include a cannabinoid device research and development facility in Israel to develop the next generation of vaporizer products, specifically for cannabis use.

Then, of course, there’s that investment from Altria and what the company is going to do with it. A new vaporizer is nice, but there has to be more, doesn’t there? The company should be proving to investors that it will boost production, diversify its products, and build its brand through acquisitions. But it’s been all quiet from this company.

One could argue that means the news will be coming in the future, but analysts aren’t so sure. As it stands, the company, even with all this cash, might be able to produce 120,000 kilos of production. Other top-tier cannabis producers are double, triple, and even beyond that.

So, while sales should continue to grow, and some news could be coming down the pipe, I’d say if you haven’t sold Cronos already, now is the time to do it. The next 12 months don’t look all that promising, with the top end of analyst prediction perhaps reaching $30 per share.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned.

More on Cannabis Stocks

Powder of Cannabis (Drugs), Analysis of Cannabis in laboratory.
Cannabis Stocks

Canopy Growth: Is There Budding Potential in the Cannabis Market?

Canopy Growth stock hit 52-week lows recently on news of needing to re-file on its BIoSteel business, so what now?

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

What’s Happening With Cannabis Stocks in May 2023?

Cannabis stocks were up this week, as the market began to turn, but how long will it last, and is…

Read more »

Cannabis smoke
Cannabis Stocks

Are Cannabis Stocks a Good Buy in May 2023?

If you're going to buy cannabis stocks, these are pretty much the only two I would consider. Even so, you…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Aurora Cannabis: Time to Light Up Your Portfolio?

Here's my take on whether Aurora Cannabis (TSX:ACB) is worth adding to a growth portfolio right now, given its growth…

Read more »

Target. Stand out from the crowd
Tech Stocks

These Undervalued TSX Stocks Are a Bargain in May 2023

If you're willing to bet on a rebound, these are the three TSX stocks I would consider first as they…

Read more »

A cannabis plant grows.
Cannabis Stocks

Tilray Stock Is Scraping 52-Week Lows: Will it Bottom Out Soon?

Tilray (TSX:TLRY) stock remains down 53% in the last year, but when will this company hit the bottom and start…

Read more »

Medicinal research is conducted on cannabis.
Metals and Mining Stocks

2 Canadian Stocks That Are Simply Too Cheap to Avoid

These two Canadian stocks have sunk lower and lower, which is why now could be the right time for long-term…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

1 Marijuana Stock I’d Buy Over Aurora Cannabis

Explore a promising marijuana stock that outshines Aurora Cannabis. Unveil the investment opportunity to boost your cannabis portfolio.

Read more »